Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. The availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. Methods: Five experimental groups (6 mice...
Main Authors: | Ajit Kulkarni, Rushil Bhat, Mansi Malik, Suvarna Sane, Sweta Kothari, Shashikant Vaidya, Abhay Chowdhary, Ranjana A. Deshmukh |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2017-03-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | http://ijms.sums.ac.ir/index.php/IJMS/article/view/2506 |
Similar Items
-
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
by: César López-Camacho, et al.
Published: (2020-06-01) -
Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
by: Jyotiranjan Bal, et al.
Published: (2018-02-01) -
<i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> Infection
by: Gustavo Cabral-Miranda, et al.
Published: (2019-07-01) -
A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
by: Emma Parker Miller, et al.
Published: (2021-09-01) -
Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate
by: Jyotiranjan Bal, et al.
Published: (2018-09-01)